Calamos Advisors LLC

Holdings History for BIOMARIN PHARMACEUTICAL INC - NOTE 1.250% 5/1

Investment type: Debt / NOTE 1.250% 5/1

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Principal	Change	Activity %	Price	All Holders
30 Sep 2025		-0%	$0	0	-16,000	-100%	95.8%	Q3 2025
30 Jun 2025	0%	0%	$15,109	16,000	0		94.43%	Q2 2025
31 Mar 2025	0%	0%	$15,133	16,000	0		94.58%	Q1 2025
31 Dec 2024	0%	0%	$14,910	16,000	0		93.19%	Q4 2024
30 Sep 2024	0%	0%	$15,295	16,000	0		95.59%	Q3 2024
30 Jun 2024	0%	0%	$15,353	16,000	0		95.96%	Q2 2024
31 Mar 2024	0%	0%	$15,909	16,000	0		99.43%	Q1 2024
31 Dec 2023	0%	0%	$16,583	16,000	0		103.64%	Q4 2023
30 Sep 2023	0%	0%	$15,930	16,000	0		99.56%	Q3 2023
30 Jun 2023	0%	0%	$16,165	16,000	0		101.03%	Q2 2023
31 Mar 2023	0%	0%	$16,768	16,000	0		104.8%	Q1 2023
31 Dec 2022	0%	0%	$17,273	16,000	0		107.96%	Q4 2022
30 Sep 2022	0%	0%	$16,000	16,000	0		100.0%	Q3 2022
30 Jun 2022	0%	0%	$16,000	16,000	0		100.0%	Q2 2022
31 Mar 2022	0%	0%	$16,000	16,000	0		100.0%	Q1 2022
31 Dec 2021	0%	0%	$17,000	16,000	0		106.25%	Q4 2021
30 Sep 2021	0%	0%	$16,000	16,000	0		100.0%	Q3 2021
30 Jun 2021	0%	+0%	$16,000	16,000	+16,000	NEW	100.0%	Q2 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.